 | • レポートコード：QAF27876 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の制限酵素市場について種類別（タイプI、タイプII、タイプIII、タイプIV、その他）、用途別（学術研究機関、病院・診断センター、バイオ医薬品、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・制限酵素市場の概要 ・世界の主要地域別制限酵素市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の制限酵素市場規模2016-2021：種類別（タイプI、タイプII、タイプIII、タイプIV、その他） ・世界の制限酵素市場予測2012-2027：種類別（タイプI、タイプII、タイプIII、タイプIV、その他） ・世界の制限酵素市場規模2016-2021：用途別（学術研究機関、病院・診断センター、バイオ医薬品、その他） ・世界の制限酵素市場予測2012-2027：用途別（学術研究機関、病院・診断センター、バイオ医薬品、その他） ・制限酵素のアメリカ市場規模と予測2016-2021 ・制限酵素のヨーロッパ市場規模と予測2016-2021 ・制限酵素の中国市場規模と予測2016-2021 ・制限酵素の日本市場規模と予測2016-2021 ・制限酵素の東南アジア市場規模と予測2016-2021 ・制限酵素のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （New England Biolabs、Thermo Fisher Scientific、Takara Bio、Illumina、Agilent Technologies、Roche、GE Healthcare、Promega Corporation、Qiagen、Jena Biosciences） ・制限酵素の製造コスト分析 ・販売チャネル、流通業者、顧客 ・制限酵素の市場動向・機会・課題 ・調査の結論 |
Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.
Till date more than 10,000 bacteria are screened for the presence of restriction enzymes and currently there are more than 2,500 restriction enzymes have been discovered along with over 250 distinct specificities in sequences. These enzymes are used in conventional cloning, deciphering epigenetic modifications, construction of DNA libraries and in vivo gene editing. The end users mainly are Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology companies.
Market Analysis and Insights: Global Restriction Endonucleases Market
The global Restriction Endonucleases market was valued at US$ 269.6 in 2020 and will reach US$ 378.1 million by the end of 2027, growing at a CAGR of 5.8% during 2022-2027.
Global Restriction Endonucleases Scope and Market Size
The global Restriction Endonucleases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Restriction Endonucleases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Type I
Type II
Type III
Type IV
Others
Segment by Application
Academic & Research Institutes
Hospitals & Diagnostic Centers
Biopharmaceutical
Others
The Restriction Endonucleases market is analysed and market size information is provided by regions (countries). Segment by Application, the Restriction Endonucleases market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent Technologies
Roche
GE Healthcare
Promega Corporation
Qiagen
Jena Biosciences
1 Restriction Endonucleases Market Overview
1.1 Restriction Endonucleases Product Scope
1.2 Restriction Endonucleases Segment by Type
1.2.1 Global Restriction Endonucleases Sales by Type (2016 & 2021 & 2027)
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.2.5 Type IV
1.2.6 Others
1.3 Restriction Endonucleases Segment by Application
1.3.1 Global Restriction Endonucleases Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Academic & Research Institutes
1.3.3 Hospitals & Diagnostic Centers
1.3.4 Biopharmaceutical
1.3.5 Others
1.4 Restriction Endonucleases Market Estimates and Forecasts (2016-2027)
1.4.1 Global Restriction Endonucleases Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Restriction Endonucleases Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Restriction Endonucleases Price Trends (2016-2027)
2 Restriction Endonucleases Estimates and Forecasts by Region
2.1 Global Restriction Endonucleases Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Restriction Endonucleases Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Restriction Endonucleases Sales Market Share by Region (2016-2021)
2.2.2 Global Restriction Endonucleases Revenue Market Share by Region (2016-2021)
2.3 Global Restriction Endonucleases Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Restriction Endonucleases Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Restriction Endonucleases Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Restriction Endonucleases Estimates and Projections (2016-2027)
2.4.2 Europe Restriction Endonucleases Estimates and Projections (2016-2027)
2.4.3 China Restriction Endonucleases Estimates and Projections (2016-2027)
2.4.4 Japan Restriction Endonucleases Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Restriction Endonucleases Estimates and Projections (2016-2027)
2.4.6 India Restriction Endonucleases Estimates and Projections (2016-2027)
3 Global Restriction Endonucleases Competition Landscape by Players
3.1 Global Top Restriction Endonucleases Players by Sales (2016-2021)
3.2 Global Top Restriction Endonucleases Players by Revenue (2016-2021)
3.3 Global Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Restriction Endonucleases as of 2020)
3.4 Global Restriction Endonucleases Average Price by Company (2016-2021)
3.5 Manufacturers Restriction Endonucleases Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Restriction Endonucleases Market Size by Type
4.1 Global Restriction Endonucleases Historic Market Review by Type (2016-2021)
4.1.1 Global Restriction Endonucleases Sales Market Share by Type (2016-2021)
4.1.2 Global Restriction Endonucleases Revenue Market Share by Type (2016-2021)
4.1.3 Global Restriction Endonucleases Price by Type (2016-2021)
4.2 Global Restriction Endonucleases Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Restriction Endonucleases Sales Forecast by Type (2022-2027)
4.2.2 Global Restriction Endonucleases Revenue Forecast by Type (2022-2027)
4.2.3 Global Restriction Endonucleases Price Forecast by Type (2022-2027)
5 Global Restriction Endonucleases Market Size by Application
5.1 Global Restriction Endonucleases Historic Market Review by Application (2016-2021)
5.1.1 Global Restriction Endonucleases Sales Market Share by Application (2016-2021)
5.1.2 Global Restriction Endonucleases Revenue Market Share by Application (2016-2021)
5.1.3 Global Restriction Endonucleases Price by Application (2016-2021)
5.2 Global Restriction Endonucleases Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Restriction Endonucleases Sales Forecast by Application (2022-2027)
5.2.2 Global Restriction Endonucleases Revenue Forecast by Application (2022-2027)
5.2.3 Global Restriction Endonucleases Price Forecast by Application (2022-2027)
6 North America Restriction Endonucleases Market Facts & Figures
6.1 North America Restriction Endonucleases Sales by Company
6.1.1 North America Restriction Endonucleases Sales by Company (2016-2021)
6.1.2 North America Restriction Endonucleases Revenue by Company (2016-2021)
6.2 North America Restriction Endonucleases Sales Breakdown by Type
6.2.1 North America Restriction Endonucleases Sales Breakdown by Type (2016-2021)
6.2.2 North America Restriction Endonucleases Sales Breakdown by Type (2022-2027)
6.3 North America Restriction Endonucleases Sales Breakdown by Application
6.3.1 North America Restriction Endonucleases Sales Breakdown by Application (2016-2021)
6.3.2 North America Restriction Endonucleases Sales Breakdown by Application (2022-2027)
7 Europe Restriction Endonucleases Market Facts & Figures
7.1 Europe Restriction Endonucleases Sales by Company
7.1.1 Europe Restriction Endonucleases Sales by Company (2016-2021)
7.1.2 Europe Restriction Endonucleases Revenue by Company (2016-2021)
7.2 Europe Restriction Endonucleases Sales Breakdown by Type
7.2.1 Europe Restriction Endonucleases Sales Breakdown by Type (2016-2021)
7.2.2 Europe Restriction Endonucleases Sales Breakdown by Type (2022-2027)
7.3 Europe Restriction Endonucleases Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Restriction Endonucleases Market Facts & Figures
8.1 China Restriction Endonucleases Sales by Company
8.1.1 China Restriction Endonucleases Sales by Company (2016-2021)
8.1.2 China Restriction Endonucleases Revenue by Company (2016-2021)
8.2 China Restriction Endonucleases Sales Breakdown by Type
8.2.1 China Restriction Endonucleases Sales Breakdown by Type (2016-2021)
8.2.2 China Restriction Endonucleases Sales Breakdown by Type (2022-2027)
8.3 China Restriction Endonucleases Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Restriction Endonucleases Market Facts & Figures
9.1 Japan Restriction Endonucleases Sales by Company
9.1.1 Japan Restriction Endonucleases Sales by Company (2016-2021)
9.1.2 Japan Restriction Endonucleases Revenue by Company (2016-2021)
9.2 Japan Restriction Endonucleases Sales Breakdown by Type
9.2.1 Japan Restriction Endonucleases Sales Breakdown by Type (2016-2021)
9.2.2 Japan Restriction Endonucleases Sales Breakdown by Type (2022-2027)
9.3 Japan Restriction Endonucleases Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Restriction Endonucleases Market Facts & Figures
10.1 Southeast Asia Restriction Endonucleases Sales by Company
10.1.1 Southeast Asia Restriction Endonucleases Sales by Company (2016-2021)
10.1.2 Southeast Asia Restriction Endonucleases Revenue by Company (2016-2021)
10.2 Southeast Asia Restriction Endonucleases Sales Breakdown by Type
10.2.1 Southeast Asia Restriction Endonucleases Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Restriction Endonucleases Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Restriction Endonucleases Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Restriction Endonucleases Market Facts & Figures
11.1 India Restriction Endonucleases Sales by Company
11.1.1 India Restriction Endonucleases Sales by Company (2016-2021)
11.1.2 India Restriction Endonucleases Revenue by Company (2016-2021)
11.2 India Restriction Endonucleases Sales Breakdown by Type
11.2.1 India Restriction Endonucleases Sales Breakdown by Type (2016-2021)
11.2.2 India Restriction Endonucleases Sales Breakdown by Type (2022-2027)
11.3 India Restriction Endonucleases Sales Breakdown by Application
11.3.1 India Restriction Endonucleases Sales Breakdown by Application (2016-2021)
11.3.2 India Restriction Endonucleases Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Restriction Endonucleases Business
12.1 New England Biolabs
12.1.1 New England Biolabs Corporation Information
12.1.2 New England Biolabs Business Overview
12.1.3 New England Biolabs Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.1.4 New England Biolabs Restriction Endonucleases Products Offered
12.1.5 New England Biolabs Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Corporation Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Thermo Fisher Scientific Restriction Endonucleases Products Offered
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Takara Bio
12.3.1 Takara Bio Corporation Information
12.3.2 Takara Bio Business Overview
12.3.3 Takara Bio Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takara Bio Restriction Endonucleases Products Offered
12.3.5 Takara Bio Recent Development
12.4 Illumina
12.4.1 Illumina Corporation Information
12.4.2 Illumina Business Overview
12.4.3 Illumina Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Illumina Restriction Endonucleases Products Offered
12.4.5 Illumina Recent Development
12.5 Agilent Technologies
12.5.1 Agilent Technologies Corporation Information
12.5.2 Agilent Technologies Business Overview
12.5.3 Agilent Technologies Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Agilent Technologies Restriction Endonucleases Products Offered
12.5.5 Agilent Technologies Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Restriction Endonucleases Products Offered
12.6.5 Roche Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare Restriction Endonucleases Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega Corporation
12.8.1 Promega Corporation Corporation Information
12.8.2 Promega Corporation Business Overview
12.8.3 Promega Corporation Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Promega Corporation Restriction Endonucleases Products Offered
12.8.5 Promega Corporation Recent Development
12.9 Qiagen
12.9.1 Qiagen Corporation Information
12.9.2 Qiagen Business Overview
12.9.3 Qiagen Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Qiagen Restriction Endonucleases Products Offered
12.9.5 Qiagen Recent Development
12.10 Jena Biosciences
12.10.1 Jena Biosciences Corporation Information
12.10.2 Jena Biosciences Business Overview
12.10.3 Jena Biosciences Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jena Biosciences Restriction Endonucleases Products Offered
12.10.5 Jena Biosciences Recent Development
13 Restriction Endonucleases Manufacturing Cost Analysis
13.1 Restriction Endonucleases Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Restriction Endonucleases
13.4 Restriction Endonucleases Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Restriction Endonucleases Distributors List
14.3 Restriction Endonucleases Customers
15 Market Dynamics
15.1 Restriction Endonucleases Market Trends
15.2 Restriction Endonucleases Drivers
15.3 Restriction Endonucleases Market Challenges
15.4 Restriction Endonucleases Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Restriction Endonucleases Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Restriction Endonucleases Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Restriction Endonucleases Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Restriction Endonucleases Sales (MT) by Region (2016-2021)
Table 5. Global Restriction Endonucleases Sales Market Share by Region (2016-2021)
Table 6. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Restriction Endonucleases Revenue Share by Region (2016-2021)
Table 8. Global Restriction Endonucleases Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Restriction Endonucleases Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Restriction Endonucleases Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Restriction Endonucleases Revenue Share Forecast by Region (2022-2027)
Table 12. Global Restriction Endonucleases Sales (MT) of Key Companies (2016-2021)
Table 13. Global Restriction Endonucleases Sales Share by Company (2016-2021)
Table 14. Global Restriction Endonucleases Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Restriction Endonucleases Revenue Share by Company (2016-2021)
Table 16. Global Restriction Endonucleases by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restriction Endonucleases as of 2020)
Table 17. Global Restriction Endonucleases Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Restriction Endonucleases Manufacturing Sites and Area Served
Table 19. Manufacturers Restriction Endonucleases Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Restriction Endonucleases Sales (MT) by Type (2016-2021)
Table 22. Global Restriction Endonucleases Sales Share by Type (2016-2021)
Table 23. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Restriction Endonucleases Price (USD/MT) by Type (2016-2021)
Table 25. Global Restriction Endonucleases Sales Share by Type (2022-2027)
Table 26. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Restriction Endonucleases Revenue Share by Type (2022-2027)
Table 28. Global Restriction Endonucleases Price (USD/MT) by Type (2022-2027)
Table 29. Global Restriction Endonucleases Sales (MT) by Application (2016-2021)
Table 30. Global Restriction Endonucleases Sales Share by Application (2016-2021)
Table 31. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Restriction Endonucleases Price (USD/MT) by Application (2016-2021)
Table 33. Global Restriction Endonucleases Sales (MT) by Application (2022-2027)
Table 34. Global Restriction Endonucleases Sales Share by Application (2022-2027)
Table 35. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Restriction Endonucleases Revenue Share by Application (2022-2027)
Table 37. Global Restriction Endonucleases Price (USD/MT) by Application (2022-2027)
Table 38. North America Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 39. North America Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 40. North America Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 42. North America Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 43. North America Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 44. North America Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 45. North America Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 46. North America Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 47. North America Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 48. North America Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 49. North America Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 50. Europe Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 51. Europe Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 52. Europe Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 54. Europe Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 55. Europe Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 56. Europe Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 57. Europe Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 58. Europe Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 59. Europe Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 60. Europe Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 61. Europe Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 62. China Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 63. China Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 64. China Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 66. China Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 67. China Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 68. China Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 69. China Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 70. China Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 71. China Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 72. China Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 73. China Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 74. Japan Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 75. Japan Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 76. Japan Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 78. Japan Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 79. Japan Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 80. Japan Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 81. Japan Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 82. Japan Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 83. Japan Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 84. Japan Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 85. Japan Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 98. India Restriction Endonucleases Sales (MT) by Company (2016-2021)
Table 99. India Restriction Endonucleases Sales Market Share by Company (2016-2021)
Table 100. India Restriction Endonucleases Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Restriction Endonucleases Revenue Market Share by Company (2016-2021)
Table 102. India Restriction Endonucleases Sales by Type (2016-2021) & (MT)
Table 103. India Restriction Endonucleases Sales Market Share by Type (2016-2021)
Table 104. India Restriction Endonucleases Sales by Type (2022-2027) & (MT)
Table 105. India Restriction Endonucleases Sales Market Share by Type (2022-2027)
Table 106. India Restriction Endonucleases Sales by Application (2016-2021) & (MT)
Table 107. India Restriction Endonucleases Sales Market Share by Application (2016-2021)
Table 108. India Restriction Endonucleases Sales by Application (2022-2027) & (MT)
Table 109. India Restriction Endonucleases Sales Market Share by Application (2022-2027)
Table 110. New England Biolabs Corporation Information
Table 111. New England Biolabs Description and Business Overview
Table 112. New England Biolabs Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. New England Biolabs Restriction Endonucleases Product
Table 114. New England Biolabs Recent Development
Table 115. Thermo Fisher Scientific Corporation Information
Table 116. Thermo Fisher Scientific Description and Business Overview
Table 117. Thermo Fisher Scientific Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Thermo Fisher Scientific Restriction Endonucleases Product
Table 119. Thermo Fisher Scientific Recent Development
Table 120. Takara Bio Corporation Information
Table 121. Takara Bio Description and Business Overview
Table 122. Takara Bio Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Takara Bio Restriction Endonucleases Product
Table 124. Takara Bio Recent Development
Table 125. Illumina Corporation Information
Table 126. Illumina Description and Business Overview
Table 127. Illumina Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Illumina Restriction Endonucleases Product
Table 129. Illumina Recent Development
Table 130. Agilent Technologies Corporation Information
Table 131. Agilent Technologies Description and Business Overview
Table 132. Agilent Technologies Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Agilent Technologies Restriction Endonucleases Product
Table 134. Agilent Technologies Recent Development
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Roche Restriction Endonucleases Product
Table 139. Roche Recent Development
Table 140. GE Healthcare Corporation Information
Table 141. GE Healthcare Description and Business Overview
Table 142. GE Healthcare Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. GE Healthcare Restriction Endonucleases Product
Table 144. GE Healthcare Recent Development
Table 145. Promega Corporation Corporation Information
Table 146. Promega Corporation Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Promega Corporation Description and Business Overview
Table 148. Promega Corporation Restriction Endonucleases Product
Table 149. Promega Corporation Recent Development
Table 150. Qiagen Corporation Information
Table 151. Qiagen Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Qiagen Description and Business Overview
Table 153. Qiagen Restriction Endonucleases Product
Table 154. Qiagen Recent Development
Table 155. Jena Biosciences Corporation Information
Table 156. Jena Biosciences Description and Business Overview
Table 157. Jena Biosciences Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Jena Biosciences Restriction Endonucleases Product
Table 159. Jena Biosciences Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Restriction Endonucleases Distributors List
Table 163. Restriction Endonucleases Customers List
Table 164. Restriction Endonucleases Market Trends
Table 165. Restriction Endonucleases Market Drivers
Table 166. Restriction Endonucleases Market Challenges
Table 167. Restriction Endonucleases Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Restriction Endonucleases Product Picture
Figure 2. Global Restriction Endonucleases Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Restriction Endonucleases Sales Market Share by Application in 2021 & 2027
Figure 6. Academic & Research Institutes Examples
Figure 7. Hospitals & Diagnostic Centers Examples
Figure 8. Biopharmaceutical Examples
Figure 9. Others Examples
Figure 10. Global Restriction Endonucleases Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Restriction Endonucleases Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Restriction Endonucleases Sales (MT) Growth Rate (2016-2027)
Figure 13. Global Restriction Endonucleases Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Restriction Endonucleases Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Restriction Endonucleases Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Restriction Endonucleases Sales (MT) Growth Rate (2016-2027)
Figure 18. Europe Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Restriction Endonucleases Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Restriction Endonucleases Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Restriction Endonucleases Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Restriction Endonucleases Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Restriction Endonucleases Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Restriction Endonucleases Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Restriction Endonucleases Players Market Share by Revenue in Restriction Endonucleases: 2016 & 2020
Figure 29. Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Restriction Endonucleases Revenue Share by Type (2016-2021)
Figure 31. Global Restriction Endonucleases Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Restriction Endonucleases Revenue Share by Application (2016-2021)
Figure 33. Global Restriction Endonucleases Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Restriction Endonucleases Sales Market Share by Type in 2020
Figure 35. North America Restriction Endonucleases Sales Market Share by Application in 2020
Figure 36. Europe Restriction Endonucleases Sales Market Share by Type in 2020
Figure 37. Europe Restriction Endonucleases Sales Market Share by Application in 2020
Figure 38. China Restriction Endonucleases Sales Market Share by Type in 2020
Figure 39. China Restriction Endonucleases Sales Market Share by Application in 2020
Figure 40. Japan Restriction Endonucleases Sales Market Share by Type in 2020
Figure 41. Japan Restriction Endonucleases Sales Market Share by Application in 2020
Figure 42. Southeast Asia Restriction Endonucleases Sales Market Share by Type in 2020
Figure 43. Southeast Asia Restriction Endonucleases Sales Market Share by Application in 2020
Figure 44. India Restriction Endonucleases Sales Market Share by Type in 2020
Figure 45. India Restriction Endonucleases Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Restriction Endonucleases
Figure 48. Manufacturing Process Analysis of Restriction Endonucleases
Figure 49. Restriction Endonucleases Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界のエクソソーム診断＆治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Exosome Diagnostic and Therapeutics Market The global Exosome Diagnostic and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…- 世界の類鼻疽診断市場規模・現状・予測（2021年-2027年） Melioidosis, also called as Whitmore's Disease, is an infectious disease caused by the bacteria Burkholderia pseudomallei. Melioidosis infection usually affects the lungs and is diagnosed by blood, urine, saliva, or skin lesion examination. Melioidosis bacteria are present in polluted water and soil…
- 世界の植物病理病害診断用試薬市場規模・現状・予測（2021年-2027年） Due to the adverse effects of climate change, the agricultural sector is at risk of major economic losses and threats to food security. This demanding situation highlights technology-driven interventions and the early detection of crop diseases such as polycyclic disease. Market Analysis and Insight…
- 世界のAI対応式診断用画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global AI-enabled Diagnostic Imaging Market The global AI-enabled Diagnostic Imaging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界の子癇前症診断市場規模・現状・予測（2021年-2027年） Preeclampsia, a rapidly progressive disorder is characterized by elevated blood pressure and excessive protein in the urine of pregnant women. Market Analysis and Insights: Global Preeclampsia Diagnostic Market The global Preeclampsia Diagnostic market size is projected to reach US$ XX million by 20…